Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Thomas D. Norton"'
Autor:
Diana Rofail, Selin Somersan-Karakaya, Eleftherios Mylonakis, Julia Y. Choi, Krystian Przydzial, Sarah Marquis, Yuming Zhao, Mohamed Hussein, Thomas D. Norton, Anna J. Podolanczuk, Gregory P. Geba
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-12 (2024)
Abstract Background The field of long COVID research is rapidly evolving, however, tools to assess and monitor symptoms and recovery of the disease are limited. The objective of the present study was to develop a new patient-reported outcomes instrum
Externí odkaz:
https://doaj.org/article/9a26a9e4274f45f9a41348f2db0edf16
Publikováno v:
JCI Insight, Vol 7, Iss 18 (2022)
Lentiviral vector–based dendritic cell vaccines induce protective T cell responses against viral infection and cancer in animal models. In this study, we tested whether preventative and therapeutic vaccination could be achieved by direct injection
Externí odkaz:
https://doaj.org/article/3bfe8cd57d9b48468cad25ba2d2392ac
Autor:
Rebecca Leibowitz, Nathaniel R. Landau, Verena van der Heide, Dirk Homann, Thomas D. Norton, Takuya Tada
Publikováno v:
Mol Ther
Dendritic cell vaccines are a promising strategy for the treatment of cancer and infectious diseases but have met with mixed success. We report on a lentiviral vector-based dendritic cell vaccine strategy that generates a cluster of differentiation 8
Autor:
Thomas D. Norton, Scott G. Kitchen, Anjie Zhen, Jennifer Kim, Nathaniel R. Landau, Takuya Tada
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy, vol 27, iss 5
Mol Ther
Mol Ther
HIV-1-infected individuals are treated with lifelong antiretroviral drugs to control the infection. A means to strengthen the antiviral Tcell response might allow them to control viral loads without antiretroviral drugs. We report the development of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::562076fd5474061926e0bb777b644ce8
https://escholarship.org/uc/item/9bh4p7wq
https://escholarship.org/uc/item/9bh4p7wq
Publikováno v:
Gene Therapy. 22:227-236
Eradication of human immunodeficiency virus-1 (HIV-1) from an infected individual requires a means of inducing production of virus from latently infected cells and stimulating an immune response against the infected cells. We report the development o
Publikováno v:
Cancer Immunology Research. 7:B121-B121
Checkpoint inhibitor therapy augments pre-existing T-cell responses to tumor antigens, resulting in tumor control in 20-40% of patients with melanoma and other cancers. As a means to increase the effectiveness of this approach, we developed a dendrit
Autor:
Elizabeth A. Miller, Thomas D. Norton
Publikováno v:
Frontiers in Immunology. 7
In the original article, an error in the references in the section entitled “Addressing Safety Concerns with LV Vaccine Vectors” is present. Reference number 20 which is cited twice in this section is an error and should instead be Di Nunzio et a
Autor:
Laura W. Musselwhite, Thomas D. Norton, Irini Sereti, Jeff Skinner, Scott R. Penzak, Adam Rupert, Brian O. Porter, Colleen Hadigan, JoAnn M. Mican, Virginia Sheikh
Publikováno v:
AIDS. 25:787-795
Objective HIV infection is associated with coagulation abnormalities and significantly increased risk of venous thrombosis. It has been shown that higher plasma levels of coagulation and inflammatory biomarkers predicted mortality in HIV. We investig
Autor:
Thomas W. Dubensky, Peter Lauer, Meredith Spadaccia, Nathaniel R. Landau, Thomas D. Norton, Dirk G. Brockstedt, Elizabeth A. Miller, Ramya Gopal, Morgan Demmler, Nina Bhardwaj, Meagan O’Brien
HIV-1 infection is characterized by myeloid dendritic cell (DC) dysfunction, which blunts the responsiveness to vaccine adjuvants. We previously showed that nonviral factors in HIV-seropositive plasma are partially responsible for mediating this immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::627c378431e41a5db7d5227ce7a5a14e
https://europepmc.org/articles/PMC4287309/
https://europepmc.org/articles/PMC4287309/
Autor:
Thomas D, Norton, Faith, Skeete, Yanina, Dubrovskaya, Michael S, Phillips, Joseph D, Bosco, Sapna A, Mehta
Publikováno v:
American journal of orthopedics (Belle Mead, N.J.). 43(5)
Data that can be used to guide perioperative antibiotic prophylaxis in our era of emerging antibiotic resistance are limited. We reviewed orthopedic surgeries complicated by surgical site infections (SSIs). Eighty percent of 69 arthroplasty and 80 sp